ロード中...
Carvedilol improves liver cirrhosis in rats by inhibiting hepatic stellate cell activation, proliferation, invasion and collagen synthesis
Portal hypertension (PHT) is one of the most severe consequences of liver cirrhosis. Carvedilol is a first-line pharmacological treatment of PHT. However, the antifibrogenic effects of carvedilol on liver cirrhosis and the intrinsic mechanisms underlying these effects have not been thoroughly invest...
保存先:
| 出版年: | Mol Med Rep |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
D.A. Spandidos
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6625452/ https://ncbi.nlm.nih.gov/pubmed/31257490 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2019.10401 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|